GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Surgery Partners SGRY · USD

Health Care · US listing · 🇺🇸 United States

Compare

26.45

+14.01%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$3.31bn

FY2016FY2025

Net income

−$77.9m

FY2016FY2025

Free cash flow

$195.6m

FY2016FY2025

Shareholders' equity

$1.71bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$3.31bn$3.11bn$2.74bn$2.54bn$2.23bn$1.86bn$1.83bn$1.77bn$1.34bn$1.15bn
Gross profit$765.0m$745.6m$647.5m$574.9m$491.4m$379.8m$423.8m$410.0m$327.4m$324.2m
Operating income$389.5m$348.8m$328.0m$345.2m$302.2m$183.0m$233.5m$77.8m$200.0m$205.7m
Net income−$77.9m−$168.1m−$11.9m−$54.6m−$70.9m−$116.1m−$74.8m−$205.7m−$53.0m$9.5m
Diluted earnings per share-0.61-1.33-0.09-0.54-0.84-2.37-1.55-4.28-1.100.20

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$8.24bn$7.89bn$6.88bn$6.68bn$6.12bn$5.41bn$5.02bn$4.68bn$4.62bn$2.30bn
Cash and short-term investments$239.9m$269.5m$195.9m$282.9m$389.9m$317.9m$92.7m$184.3m$174.9m$69.7m
Total liabilities$4.72bn$4.25bn$3.51bn$3.40bn$3.82bn$3.79bn$3.32bn$4.68bn$4.62bn$2.30bn
Debt$3.74bn$3.37bn$2.78bn$2.62bn$2.94bn$2.86bn$2.58bn$2.48bn$2.31bn$1.49bn
Shareholders' equity$1.71bn$1.79bn$1.99bn$2.00bn$1.09bn$550.1m$691.8m$404.6m$654.7m$9.7m
Shares outstanding127m126m126m102m85m49m48m48m48m48m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$274.3m$300.1m$293.8m$158.8m$87.1m$246.9m$129.5m$144.6m$120.9m$125.2m
Capital spending−$78.7m−$90.4m−$88.8m−$80.6m−$57.6m−$42.9m−$73.6m−$39.8m−$29.6m−$39.1m
Free cash flow$195.6m$209.7m$205.0m$78.2m$29.5m$204.0m$55.9m$104.8m$91.3m$86.1m
Dividends paid———−$146.8m−$5.1m−$109.6m−$121.2m−$7.8m−$1.3m−$85.9m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$848.9m$810.9m$885.0m$821.5m$826.2m$776.0m$864.4m$770.4m
Gross profit$190.2m$121.7m$212.2m$195.3m$195.6m$161.9m$233.6m$177.5m
Operating income$102.1m$82.4m$110.2m$105.7m$111.7m$61.9m$180.0m$60.9m
Net income−$15.0m−$35.9m−$15.0m−$22.7m−$2.5m−$37.7m−$108.5m−$31.7m
Diluted earnings per share-0.12-0.28-0.12-0.18-0.02-0.30-0.86-0.25
Cash from operations$59.0m$11.0m$103.0m$83.0m$81.0m$6.0m$111.0m$65.0m
Capital spending−$21.0m−$16.0m−$12.0m−$19.0m−$23.0m−$22.0m−$22.0m−$20.0m
Free cash flow$38.0m−$5.0m$91.0m$64.0m$58.0m−$16.0m$89.0m$45.0m
Total assets$8.05bn$8.04bn$8.24bn$7.95bn$7.95bn$7.95bn$7.89bn$7.53bn
Cash and short-term investments$216.7m$182.3m$239.9m$203.4m$250.1m$229.3m$269.5m$221.8m
Debt$102.9m$3.76bn$3.74bn$3.60bn$3.61bn$3.59bn$3.41bn$3.23bn
Shareholders' equity$1.67bn$1.69bn$1.71bn$1.73bn$1.75bn$1.74bn$1.79bn$1.90bn

Financial ratios

Data as of 30 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin23.1%23.9%23.6%22.6%22.1%20.4%
Operating margin11.8%11.2%12.0%13.6%13.6%9.8%
Net margin-2.4%-5.4%-0.4%-2.2%-3.2%-6.2%
Return on equity-4.5%-9.4%-0.6%-2.7%-6.5%-21.1%
Return on assets-0.9%-2.1%-0.2%-0.8%-1.2%-2.1%
Free cash flow yield12.0%13.3%13.1%10.1%7.4%25.5%
Revenue growth6.2%13.5%8.0%14.1%19.6%1.6%
Earnings growth-53.7%1312.6%-78.2%-23.0%-38.9%55.2%
Current ratio1.87x1.79x1.71x1.87x1.76x1.44x
Debt to equity2.19x1.91x1.42x1.33x2.74x5.26x
Equity ratio20.8%22.7%28.9%29.9%17.8%10.2%
Interest coverage1.43x1.73x1.70x1.47x1.37x0.91x
Buybacks as a share of market value-0.8%-0.3%-23.4%-20.5%-72.9%-1.2%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue9.2%12.2%13.2%
Operating income4.1%16.3%10.4%
Net income12.6%-7.7%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin23.5%23.3%22.8%23.6%
Operating margin11.5%12.1%12.0%12.1%
Net margin-3.8%-2.7%-3.2%-3.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-25.2-15.9-338.1-52.0-63.7-12.2-10.1-2.3-11.051.3
Price to sales0.60.91.51.12.00.80.40.30.40.4

Market value over time

30 Nov 2016 to 29 Oct 2026, in USD

$708.3m$2.99bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-20%-39%28%-44%63%76%46%2%18%-27%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.